Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
Ornella Verrastro(Agostino Gemelli University Polyclinic), Geltrude Mingrone(University of the Sacred Heart), Marco Raffaelli(Università Cattolica del Sacro Cuore), Luca Sessa(Saint Camillus International University of Health and Medical Sciences), Francesco Rubino(King's College Hospital), Laura Riccardi(Università Cattolica del Sacro Cuore), Maria Assunta Zocco(Università Cattolica del Sacro Cuore), Ivo Boškoski(Università Cattolica del Sacro Cuore), Erminia Lembo(Università Cattolica del Sacro Cuore), Giovanni Casella(Sapienza University of Rome), James Casella-Mariolo(ASL Roma), Lidia Castagneto‐Gissey(Policlinico Umberto I), Francesco Pennestrì(Università Cattolica del Sacro Cuore), Caterina Guidone(Agostino Gemelli University Polyclinic), Andrea De Gaetano(Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti), Enrico Fiori(Sapienza University of Rome), Maurizio Pompili, Giulia Angelini(Università Cattolica del Sacro Cuore), Pierluigi Marini(Carlo Forlanini Hospital), Simona Panunzi(Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti), Esmeralda Capristo(Università Cattolica del Sacro Cuore), Fabio Maria Vecchio(Agostino Gemelli University Polyclinic), Stefan R. Bornstein(King's College London)
Cited by 338
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k